Quest Partners LLC Acquires Shares of 353 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Quest Partners LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 353 shares of the medical equipment provider’s stock, valued at approximately $173,000.

Several other large investors have also bought and sold shares of ISRG. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. LRI Investments LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. This trade represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,459 shares of company stock valued at $26,080,251. Company insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $526.06.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The firm has a fifty day moving average price of $507.94 and a 200-day moving average price of $466.79. The company has a market cap of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.